3 results match your criteria: "Changsha Hospital of Traditional Chinese Medicine (Changsha No. 8 Hospital)[Affiliation]"
Influence of myosteatosis on survival of patients with pancreatic cancer: A systematic review and meta-analysis.
iScience
December 2024
Department of Critical Care Medicine, Changsha Hospital of Traditional Chinese Medicine (Changsha No. 8 Hospital), Changsha City, Hunan Province 410100, P.R. China.
The present meta-analysis aims to evaluate the impact of myosteatosis on overall survival (OS) and progression-free survival (PFS) in patients with pancreatic cancer (PC). A comprehensive literature search was conducted in the Medline, Web of Science, and Embase databases. The hazard ratio (HR) and corresponding 95% confidence interval (CI) for the association between myosteatosis and survival outcomes were pooled using a random-effects model.
View Article and Find Full Text PDFImpact of elevated lipoprotein(a) levels on the functional outcomes of ischemic stroke patients: A systematic review and meta-analysis.
Eur J Neurol
December 2024
Department of Neurology, Changsha Hospital of Traditional Chinese Medicine (Changsha No. 8 Hospital), Changsha, China.
Article Synopsis
- * A systematic review and meta-analysis of 11 studies involving nearly 12,000 IS patients showed that high baseline Lp(a) levels significantly increase the risk of unfavorable outcomes, especially right after the stroke and within the first six months.
- * The findings suggest that monitoring Lp(a) levels could be important in understanding and managing stroke recovery, though the connection is somewhat influenced by the levels of low-density lipoprotein cholesterol (LDL-C).
Serum Cytokeratin-18 levels as a prognostic biomarker in advanced liver disease: a comprehensive meta-analysis.
Clin Exp Med
July 2024
Department of Critical Care Medicine, Changsha Hospital of Traditional Chinese Medicine (Changsha No. 8 Hospital), 22 Xingsha Avenue, Changsha City, Hunan Province, 410100, People's Republic of China.
Cytokeratin-18 (CK-18) is a marker of hepatic cell death. Serum CK-18 could serve as a prognostic marker for patients with advanced liver disease (ALD). This meta-analysis aims to explore the association between total CK-18 (M65) and caspase-cleaved CK-18 (M30) levels with the prognosis of ALD patients.
View Article and Find Full Text PDF